301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

301 Association of response with survival outcomes with atezolizumab in combination with vemurafenib and cobimetinib in the phase 3 IMspire150 study

Bibliographic Details
Main Authors: Ralf Gutzmer, Caroline Robert, Thomas Eigentler, Qian Zhu, Helen Gogas, Grant McArthur, Paolo Ascierto, Daniil Stroyakovskiy, Svetlana Protsenko, Rodrigo Pereira, Lev Demidov, Georgy Moiseevich Manikhas, Haocheng Li, Edward McKenna, Virginia McNally
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items